AACR-Kids Beating Cancer Margaret Guedes Monosomy 7 Legacy Cancer Research Grant

Support basic, translational, clinical or population research on monosomy 7 AML and other rare, high-risk cytogenetic AML subtypes. Projects should address mechanisms, therapeutic vulnerabilities, biomarkers, treatment response, relapse or survivorship, producing useful diagnostic, therapeutic or trial-enabling findings. The three-year term begins 1 April 2027. Applications are due 1 December 2026 at 13:00 U.S. Eastern Time.

Related doctoral degree and independent, non-mentored research position by 1 April 2027. Academic, medical or research host worldwide; work status must cover the term. Active AACR membership required by submission. No further doctoral candidature, U.S. federal or for-profit employment, or overlapping AACR grant.